CA125 as a serum marker for poor prognosis in ovarian malignancies.


In cancer of the ovary, a tumor marker is much needed to assist the conventional methods for monitoring the disease course. All published reports of the CA125 serum immunoassay to date have indicated that rising or falling CA125 levels correlated with disease progression or regression in patients with ovarian malignancies. Our experience with CA125 at the… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.